Top Tweets for #PracticeChanging
🔥🚨@OncoAlert Hot off the press.
Just presented @ASCO #ASCO26 (#Plenary Presentation) by Dr. Jonathan Goldman.
⭐️Results of #PracticeChanging #LIBRETTO432 Trial of:
#Adjuvant #Selpercatinib vs #Placebo
in Early-Stage (IB-IIIA) #RET+ Non-Small-Cell #LungCancer.
✅⬆️#EFS
❇️#HR: 0.17 for stage II-IIIA
2-year EFS: 92% vs 61%
❇️#HR: 0.16 for stage IB-IIIA
2-year EFS: 94% vs 70%
🎯‼️#NEW #StandardOfCare
📣Results published simultaneously @NEJM (See tweet/post below👇🏻)
🔥🚨@OncoAlert Hot off the press.
Just published @NEJM In conjunction with presentation @ASCO #ASCO26.
⭐️Results of #PracticeChanging #LIBRETTO432 Trial of:
#Adjuvant #Selpercatinib vs #Placebo
in Early-Stage (IB-IIIA) #RET+ Non-Small-Cell #LungCancer.
✅⬆️#EFS
❇️#HR: 0.17 for stage II-IIIA
2-year EFS: 92% vs 61%
❇️#HR: 0.16 for stage IB-IIIA
2-year EFS: 94% vs 70%
🎯‼️#NEW #StandardOfCare
👇🏻
https://t.co/u6PLyTLCqr
🔥🚨@OncoAlert Hot off the press.
Just published @NEJM In conjunction with presentation @ASCO #ASCO26.
⭐️Results of #PracticeChanging #LIBRETTO432 Trial of:
#Adjuvant #Selpercatinib vs #Placebo
in Early-Stage (IB-IIIA) #RET+ Non-Small-Cell #LungCancer.
✅⬆️#EFS
❇️#HR: 0.17 for stage II-IIIA
2-year EFS: 92% vs 61%
❇️#HR: 0.16 for stage IB-IIIA
2-year EFS: 94% vs 70%
🎯‼️#NEW #StandardOfCare
👇🏻
https://t.co/u6PLyTLCqr
Our UChicago Post-ASH is just one week away!! There's still time to register at https://t.co/Ann6ISiogR
#ASH #PracticeChanging #CancerCare #CancerResearch
#VESALIUS-CV trial: in pts at high CV risk w/o a prior event, the addition of evolocumab to baseline LLRx showed a significant reduction in MACE!! CV death & all cause death were lower.. Results consistent across all sub-groups… #AHA2025 #LBCT #PracticeChanging @AHAScience
Honored to Have Been The Senior Author of The Plenary Abstract of the Phase III SURPASS-ETs Trial at EHA25 - Ruben Mesa
@mpdrc @EHA_Hematology @HarryGillHKUMed
https://t.co/jbQEqPl4ad
#Cancer #EssentialThrombocythemia #MedX #MedNews #MedEd #PracticeChanging #EHA25 #Medicine #Health #Oncology #OncoDaily
Honored to have been the senior author of this #PlenaryAbstract at #EHA25 (presented by great colleague @HarryGillHKUMed ) of the Phase III #Superiority of #ROPEG over #ANAGRELIDE in 2L for ET #PracticeChanging
@LevineCancer @wakeforestmed @AtriumHealth @PharmaEssentia
Amazing #PracticeChanging #ASCO25 results led by our own Dr Peter Voorhees @PlasmaCellPete , Associate Director of Clinical Research @AtriumHealthWFB Comprehensive Cancer Center @wakeforestmed @LevineCancer
After terminally ill patients tried a last-ditch blood cancer treatment, doctors are talking about a potential cure. https://t.co/LoXYqdc29F
Breakthroughs, buzz, bad coffee + the best people in oncology. ASCO, you never disappoint.
#ASCO25 #LatteGirl #CancerResearch #Oncology #ClinicalTrials #PracticeChanging #MedEd #WomenInMedicine #womeninoncology @ASCO
Amazing #PracticeChanging #ASCO25 results led by our own Dr Peter Voorhees @PlasmaCellPete , Associate Director of Clinical Research @AtriumHealthWFB Comprehensive Cancer Center @wakeforestmed @LevineCancer
A possible game-changer for those battling relapsed/refractory multiple myeloma (RRMM). 🩸Our study shows that 33% of patients treated with cilta-cel have remained progression-free for ≥5 years. #ASCO25 Link: https://t.co/MA1BE7CJDQ
Up next at LBA session at #ESTRO25 is @DrSineadBrennan presenting results of @IRROGTrials OPEN study based at St Luke’s Radiation Oncology Network
1st RCT in this area:
➡️ 3 point OPEN masks superior:
➡️ Improved patient experience
#PracticeChanging
#LateBreaking #STRIDE #PAD #DM2 #Simaglutide saw significant benefit in symptoms and #ABI 🔥🔥
#GLP1 drug again impressed with outcomes, Now in the field of PAD, regardless of their #BMI
#PracticeChanging ?? Thoughts??
#ACC25 @ACCinTouch 🫀
#ESOPEC - periop FLOT vs neoadjuvant CROSS in resectable ESO/GEJ adeno - publication out today! @NEJM
#practicechanging
@OncoAlert @OncEd
🔗 https://t.co/FxSdkexlyL
@juanpabloarab @AnandVKulkarni2 @AIGHospitals @AASLDtweets Hearty Congratulations Team!! #PracticeChanging
🚨🔥2/2 This #PracticeChanging results of #ADRIATIC trial showed:
✅ ⬆️ #mOS: 55.9 vs 33.4 months (HR 0.73)
✅ ⬆️ #mPFS: 16.6 vs 9.2 months (HR 0.76)
Was a pleasure to sit down with my good friend @Daniel_J_George and talk about a truly #practicechanging trial in #prostatecancer.
Novel hormonal therapies for high-risk biochemical recurrence: the #EMBARK trial. @SFreedlandMD @CSCancerCenter joins @Daniel_J_George @DukeCancer to discuss the EMBARK study and highlight its significant impact on metastasis-free survival. #WatchNow > https://t.co/0iF1KCnRGR
@NephJC From now on, I'll be like, "Here is your 2-yr and 5-yr risk for dialysis...but because you have a rare kidney disease it is worse."
#PracticeChanging
#NephJC
The #PV GOAT 🐐(or in French “Le Bouc”) Prof JJ Kiladjian @jjkiladjian sharing important data that JAK2-V617F molecular response correlates with event free survival! #PracticeChanging #EHA2024 @doctorpemm @harrisoncn1 #ROPEG #MPNSM
Last Seen Hashtags on Sotwe
ควย56
Seen from Thailand
agegap
Seen from Peru
khagariabihar
Seen from Brazil
กลุ่มไลน์ฟรี
Seen from Thailand
ชายเดี่ยวชะอำ
Seen from Thailand
jbalvinxtakashimurakami
Seen from United Kingdom
ninjaripper
Seen from Brazil
غزاله_صدر_گیلانی
Seen from Brazil
hitsongformula
Seen from Brazil
tamil_cuckold
Seen from France
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
240.2M followers
Barack Obama
@barackobama
119.3M followers
Donald J. Trump
@realdonaldtrump
111.6M followers
Cristiano Ronaldo
@cristiano
108.9M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.3M followers
NASA
@nasa
92.1M followers
Justin Bieber
@justinbieber
90.6M followers
KATY PERRY
@katyperry
86.8M followers
Taylor Swift
@taylorswift13
80.6M followers
Lady Gaga
@ladygaga
72.2M followers
Kim Kardashian
@kimkardashian
69.4M followers
YouTube
@youtube
68.6M followers
Virat Kohli
@imvkohli
68.5M followers
Bill Gates
@billgates
63.4M followers
The Ellen Show
@theellenshow
62.5M followers
CNN
@cnn
61.9M followers
Neymar Jr
@neymarjr
61.1M followers
X
@x
60.9M followers
Selena Gomez
@selenagomez
59.9M followers